Patent application number | Description | Published |
20080267189 | METHOD AND SYSTEM FOR VERIFYING UPDATE INFORMATION IN BGP - A method for verifying update information in Border Gateway Protocol (BGP), includes: upon receipt of an update message, verifying, by an Autonomous System (AS), the update message according to a determined maximum time of verifications; and trusting the update message if the verifications are successful. The update message may be AS_PATH and/or prefix. In the invention, upon receipt of an update message, the AS verifies the update information according to the maximum time of verifications, which ensures that the time of verifications will not exceed the maximum time of verifications when the AS verifies the update information. Accordingly, load on CPU is decreased during verification of the update information and hence the network convergence speed is improved. | 10-30-2008 |
20080273509 | Method, System And Device For Optimizing Routing In Mobile IPv6 - This disclosure relates to a method, system and device for optimizing routing in a mobile IPv6. The core is that the communication between a mobile node and a correspondence node is performed in a routing optimization mode, while providing a secure verification, so that the care-of address of the mobile node would not be obtained by a distrustful third party or a distrustful correspondence node. Moreover, to further ensure the privacy of the location of the mobile node, the current care-of address of the mobile node is shielded from the correspondence node by separating the binding cache from the correspondence node. | 11-06-2008 |
Patent application number | Description | Published |
20100016314 | DERIVATIVES OF AZABICYCLO OCTANE, THE METHOD OF MAKING THEM AND THE USES THEREOF AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV - Derivatives of azabicyclo octane presented by formula (I), the method of making them, and the compositions containing the same and the uses thereof as inhibitors of dipeptidyl peptidase IV (DPP-IV), wherein the substitutes in formula (I) have the same meanings as what is mentioned in the descriptions. | 01-21-2010 |
20100316601 | BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF - The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description. | 12-16-2010 |
20120245380 | Inhibition of Ornithine Aminotransferase for the Treatment of Proliferative Disorders - The invention relates to inhibition of ornithine aminotransferase (OAT) for suppression of tumor cells proliferation. More particularly, the invention relates to methods of treatment of proliferative disorders by the selective inhibition of OAT, and further provides the use of OAT inhibitors, specifically, 5-amino-1,3-hexadienyl-carboxylic acid (Gabaculine), and Gabaculine analogue 8, for compositions and methods for the treatment of proliferative disorders such as hepatocellular carcinoma. The invention further provides methods and kits for the diagnosis of a pathologic proliferative disorder in a mammalian subject, based on determining the level of OAT expressed in a biological sample obtained from a subject. | 09-27-2012 |
20130123507 | BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF - The bicyclo-substituted pyrazolon-azo derivatives of formula (I) or pharmaceutical acceptable salts, hydrates or solvates thereof, methods for their preparation, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor are disclosed. The definition of substituents in formula (I) are the same as defined in the description. | 05-16-2013 |
20140140953 | SALTS OF BICYCLO-SUBSTITUTED PYRAZOLON AZO DERIVATIVES, PREPARATION METHOD AND USE THEREOF - The pharmaceutically acceptable salts of bicycle-substituted pyrazolon azo derivatives represented by the general formula (I), their preparation methods, pharmaceutical compositions containing the same and their use as a therapeutic agent, especially as thrombopoietin (TPO) mimetics and their use as agonists of thrombopoietin receptor. The definitions of substituents in the general formula (I) are the same as the description. | 05-22-2014 |
Patent application number | Description | Published |
20080293563 | Activated carbon supported cobalt based catalyst for directly converting of synthesis gas to mixed linear alpha-alcohols and parafins - The invention provides an activated carbon supported cobalt based catalyst for directly converting of synthesis gas to mixed linear alpha-alcohols and paraffins, comprising cobalt, an activated carbon carrier, a metal promoter which is at least one selected from the group consisting of a zirconium component, a lanthanum component, a cerium component, a chromium component, a vanadium component, a titanium component, a manganese component, a rhenium component, a potassium component, a ruthenium component, a magnesium component and a mixture thereof, wherein the cobalt and the promoter are deposited on the activated carbon carrier or substantially uniformly dispersed therein, and the metal promoter is present in the form of a metal, an oxide or a combination thereof. | 11-27-2008 |
20080293835 | PROCESS FOR DIRECTLY PRODUCING MIXED LINEAR ALPHA-ALCOHOLS HAVING 1 TO 18 CARBON ATOMS FROM SYNTHESIS GAS - The invention provide a process for producing directly mixed linear alpha-alcohols having 1 to 18 carbon atoms from synthesis gas comprising hydrogen and carbon monoxide, comprising the step of reacting hydrogen and carbon monoxide over a catalyst to produce mixed linear alpha-alcohols having 1 to 18 carbon atoms and hydrocarbons having 1 to 25 carbon atoms through Fischer-Tropsch process in one step in a reactor, wherein: the mole ratio of hydrogen to carbon monoxide is within the range of 1 to 3; the catalyst is an activated carbon supported cobalt based catalyst; the reactor is a fixed bed reactor, a slurry reactor or a fluid reactor; the reaction is carried out under specific conditions. | 11-27-2008 |